PurposeTo explore the association between baseline osteoarthritis (OA)-related magnetic resonance (MR) imaging features and pain reduction after genicular artery embolization (GAE) in patients with mild-to-moderate symptomatic knee OA resistant to conservative therapy. Materials and MethodsThis was a retrospective analysis of patients with mild-to-moderate symptomatic knee OA treated with GAE using imipenem-cilastatin sodium. The clinical outcome was scored at baseline and 6 months after treatment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). MR images were scored using the MR imaging osteoarthritis knee score. Linear regression was used to evaluate associations of before-treatment MR imaging scores with WOMACpain and WOMACtotal reduction after 6 months. ResultsFifty-four patients (22.2% male; median age, 69.4 years; median WOMACpain at baseline, 12) were evaluated. Of all OA features scored, a higher cartilage full-thickness defect score showed the strongest association with less reduction of both WOMACpain (B,−0.63 [95% confidence interval (CI), −0.91 to −0.34]; P < .001) and WOMACtotal scores (B, −1.77 [95% CI, −2.87 to −0.67]; P < .001) following treatment. The presence of grade 2–3 effusion synovitis (B, −2.99 [95% CI, −5.39 to −0.60]) bone marrow lesions (B, −0.52 [95% CI, −0.86 to −0.19]), osteophytes (B, −0.21 [95% CI, −0.36 to −0.06]), and cartilage defect surface area score (B, −0.25 [95% CI −0.42 to −0.08]) all showed a significant association with less WOMACpain reduction (all P < .05). ConclusionsIn patients with mild-to-moderate symptomatic knee OA treated with GAE, the presence and severity of full-thickness cartilage defects, effusion synovitis, bone marrow lesions, osteophytes, and cartilage surface area scores at baseline are associated with less favorable clinical outcomes at 6 months.